Menu
← Oncology Approval Tracker
FDA DECISION ·
Pralatrexate (Folotyn reference)
pralatrexate · Dr. Reddy’s Laboratories
Open LinkedIn brief ↓1 min read · estimated
APPROVED USE
What FDA approved
First generic pralatrexate injection for relapsed or refractory peripheral T-cell lymphoma.
LAMPGEN ANALYSIS
Why it matters
The approval added an alternative source for an antifolate used in recurrent peripheral T-cell lymphoma.
What research teams should watch
Keep vitamin supplementation, blood count monitoring, and mucositis checks in the infusion workflow across suppliers.
PRIMARY RECORDS